Medtronic seeks FDA nod for Hugo robotic surgery system

Sundry Photography/iStock Editorial via Getty Images Medtronic ( NYSE: MDT ) confirmed on Saturday the submission of regulatory filings with the FDA to obtain marketing approval for its Hugo robotic-assisted surgery system in the U.S., targeting a urologic indication.

The filings for the Hugo RAS system were submitted in.